Trial · Interventional
CompletedPhase 4Registry dataThe Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
Short name T2DM
Overview
- Status
- Completed
- Phase
- Phase 4
- Enrollment
- 16 participants (actual)
- Sponsor
- Baylor College of Medicine · Other
- Design
- Randomized · Single masking
- Countries
1 country
United States
- Start
- Jul 2009
- Primary completion
- May 2011
- Completion
- May 2011
- First posted
- 3 Aug 2009 (estimated)
- Last update posted
- 24 Apr 2017
- Conditions
- Type 2 Diabetes
Timeline
1 trial · 1 completed
- Completed
- Ongoing
- Not yet recruiting
- Stopped
- Estimated dates (est.)
- Results posted
- Ph 4
Registry summary
Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.
The purpose of this study is to see if giving study drugs before a meal may lower blood sugars after the meal. An improvement in blood sugar control may prevent long-term problems of diabetes.
Interventions
- Byetta (exenatide)Drug
- Symlin (pramlintide)Drug
Arms2
Active comparator
exenatide
exenatide one dose
Active comparator
pramlintide
pramlintide one dose
Primary outcomes1
Outcomes the sponsor listed as primary.
Glucose
Time frame · 4 hours
Registry description
concentration and AUC calculations
Secondary outcomes(4)
glucagon
Time frame · 4 hrours
Registry description
concentration and AUC calculations
gastric emptying
Time frame · 4 hours
Registry description
concentration and AUC calculations
pramlintide concentrations
Time frame · 4 hours
Registry description
concentration and AUC calculations
exenatide concentrations
Time frame · 4 hours
Registry description
concentration and AUC calculations
Posted results
Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.
No results are posted for this trial.
Completed trials do not always post results.
Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works
Studies0
Studies that cite this trial.
No study cites this trial.
Eligibility
Who could join, as posted.
- Sex
- All
- Age
- from 12 Years up to 21 Years
- Healthy volunteers
- Not accepted
Inclusion and exclusion criteria, as posted
PepBank is a research reference. Talk to a doctor before you use any peptide.